288
Participants
Start Date
December 31, 2016
Primary Completion Date
December 31, 2018
Study Completion Date
August 31, 2019
TPO
The First Hospital of China Medical University, Shenyang
Harbin Institute of Hematology and Oncology, Haerbin
First Affiliated Hospital Heilongjiang University of Chinese Medicine, Shenyang
The Second Affiliated Hospital of Soochow University, Suzhou
The First Affiliated Hospital of Anhui Medical University, Hefei
Chinese Academy of Medical Sciences Blood Disease Hospital, Tianjin
Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine, Hangzhou
Lishui City Center Hospital, Lishui
Zhongshan Hospital Xiamen University, Xiamen
Loudi Central Hospital, Loudi
renmin Hospital of Wuhan University Hubei General Hospital, Wuhan
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou
Zhengzhou Central Hospital, Zhengzhou
Xinxiang Central Hospital,, Xinxiang
Henan University of Science and Technology First Affiliated Hospital, Luoyang
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
Guangdong Second People's Hospital, Guangzhou
Guangzhou Panyu Central Hospital, Guangzhou
Xi An Central Hospital, Xi’an
Xinjiang Uygur Autonomous Region Chinese Medicine Hospital,, Ürümqi
The First Affiliated Hospital of Xinjiang Medical University, Xinjiang
Shenyang Sunshine Pharmaceutical Co., LTD.
INDUSTRY